Do elevated zonulin family peptide and fecal secretory IgA reflect gut barrier disruption linked to autoimmune thyroid antibodies?

The gut-thyroid axis represents a vital physiological pathway where intestinal barrier integrity and mucosal immunity directly modulate systemic autoimmune processes.

Mechanistic pathways of gut-thyroid reactivity

• Tight junction disassembly: Zonulin acts as a physiological regulator of epithelial tight junctions. Its upregulation—often triggered by gliadin or dysbiosis—leads to tight junction disassembly and paracellular barrier disruption.
• Antigen translocation and mucosal activation: Compromised barrier integrity allows the translocation of luminal macromolecular antigens, lipopolysaccharides (LPS), and dietary proteins into the lamina propria, stimulating a localized mucosal immune response and elevated fecal secretory IgA (sIgA).
• Systemic immune cascade: Antigen-presenting cells process these translocated antigens, driving a systemic Th17/Treg imbalance and the chronic release of pro-inflammatory cytokines, including IL-6, IL-17, and TNF-α.
• Autoimmune thyroid activation: This pro-inflammatory milieu, combined with molecular mimicry between thyroid proteins and translocated dietary or microbial antigens, drives the bystander activation of autoreactive lymphocytes. This process promotes the generation of autoimmune thyroid antibodies, particularly thyroid peroxidase (TPO) antibodies, in genetically susceptible individuals.

Clinical evidence and diagnostics

• Clinical biomarkers: Patients with Hashimoto’s thyroiditis consistently exhibit elevated levels of the paracellular permeability marker zonulin.
• Diagnostic considerations: While elevated fecal sIgA reliably indicates active mucosal defense against pathogens or food antigens, clinical interpretation of zonulin family peptides requires caution due to specificity limitations in commercial ELISA assays.

Bottom line

• Elevated zonulin and fecal sIgA represent distinct but complementary pathways where intestinal barrier breakdown and mucosal activation drive the systemic immune dysregulation and molecular mimicry that promote autoimmune thyroid antibody production.